Samsung Biologics is a fully integrated end-to-end service provider offering development and manufacturing services, all at one site. We provide highly tailored solutions to clients, while meeting the evolving needs of the global healthcare industry.
With proven regulatory approvals, Samsung Biologics is a trusted CDMO partner of choice and is uniquely able to provide seamless offerings from cell line development to final aseptic fill/finish for biologics. To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demands, Samsung Biologics is constructing a fourth plant, which will further advance the company’s standing as the world’s largest manufacturing facility at a single site—holding a 604KL total capacity upon full completion in mid-2023. Our facilities are all cGMP compliant with bioreactors ranging from small to large scales. We continue to upgrade our capabilities to accommodate our clients by investing in single-use technology and additional aseptic filling capacity.
Additionally, Samsung Biologics’ R&D Center in South San Francisco is equipped for high-quality cell line development, and our Sales Office in Ridgefield Park, New Jersey, enables the company to work in closer proximity to clients based in the U.S. and Europe. We are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise.
Your Trusted CDMO Partner,
Samsung Biologics
With proven regulatory approvals, Samsung Biologics is a trusted CDMO partner of choice and is uniquely able to provide seamless offerings from cell line development to final aseptic fill/finish for biologics. To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demands, Samsung Biologics is constructing a fourth plant, which will further advance the company’s standing as the world’s largest manufacturing facility at a single site—holding a 604KL total capacity upon full completion in mid-2023. Our facilities are all cGMP compliant with bioreactors ranging from small to large scales. We continue to upgrade our capabilities to accommodate our clients by investing in single-use technology and additional aseptic filling capacity.
Additionally, Samsung Biologics’ R&D Center in South San Francisco is equipped for high-quality cell line development, and our Sales Office in Ridgefield Park, New Jersey, enables the company to work in closer proximity to clients based in the U.S. and Europe. We are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise.
Your Trusted CDMO Partner,
Samsung Biologics
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
